Preventing airborne infection: Pulmotect arms the lungs with extra immunity
Pulmotect, a Houston-area biotech, has a drug that could rev up a patient's immune system in the lungs. It just received a $3 million grant from the NIH to learn whether its drug prevents pneumonia in cancer patients.